Detalhe da pesquisa
1.
Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab.
Hepatology
; 79(1): 49-60, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870270
2.
Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
Hepatology
; 77(2): 430-442, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980227
3.
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver Int
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436538
4.
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC.
Liver Int
; 44(4): 931-943, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291735
5.
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence.
Liver Int
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581233
6.
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab.
Liver Int
; 43(3): 708-717, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444741
7.
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Ann Hepatol
; 28(6): 101141, 2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468096
8.
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
Hepatology
; 74(1): 364-378, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33345307
9.
Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease.
Liver Int
; 42(4): 905-917, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894060
10.
A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCC.
Liver Int
; 42(12): 2843-2854, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36254617
11.
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Liver Int
; 42(8): 1891-1901, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608939
12.
Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma.
Mod Pathol
; 34(2): 408-416, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860001
13.
Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.
J Gastroenterol Hepatol
; 35(1): 142-150, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237018
14.
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.
Am Heart J
; 198: 4-17, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653647
15.
Benign liver tumors / Diagnostic des tumeurs hépatiques bénignes
Rev Prat
; 68(10): 1119-1124, 2018 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-30869222
16.
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab.
Dig Liver Dis
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548580
17.
Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
Aliment Pharmacol Ther
; 58(3): 346-356, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300315
18.
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC.
Clin Res Hepatol Gastroenterol
; 47(8): 102199, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666414
19.
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors.
Dig Liver Dis
; 55(7): 938-944, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019737
20.
The liver in sickle cell disease.
Presse Med
; 52(4): 104212, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981193